Schott Pharma AG & CO KGaA (XTER:1SXP)
€ 27.6 0.32 (1.17%) Market Cap: 4.16 Bil Enterprise Value: 4.20 Bil PE Ratio: 26.48 PB Ratio: 5.20 GF Score: 28/100

Q3 2024 SCHOTT Pharma AG & Co KgaA Earnings Call Transcript

Aug 29, 2024 / 09:00AM GMT
Release Date Price: €35.8 (+11.25%)
Operator

Good morning, ladies and gentlemen, and welcome to the SCHOTT Pharma conference call for the nine months 2023, 2024. (Operator Instructions) Let me now turn the floor over to your host, Jasko Terzic.

Jasko Terzic
SCHOTT Pharma AG & Co KgaA - Head - Investor Relations

Hello, everyone, and thank you for joining SCHOTT Pharma's earnings call for the third quarter of fiscal year 2024. My name is Jasko Terzic, Senior Manager, Investor Relations, and I will be the host of our call today. With me today our CEO, Andreas Reisse, who joined us remotely, Our CFO, Dr. Almuth Steinkuhler, and Tobias Erfurth, our new Head of Investor Relations, who joined us only two weeks ago.

Andreas will start today's call by providing an update on SCHOTT pharma strategy and business development and the third quartering of fiscal 2024. Followed by Almuth, who will take us through our financials for the period. Finally, Andreas will conclude the presentation before we start the Q&A session.

Before we begin, I would like to direct your attention to our disclaimer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot